The cancer risk with "light" drinking
Update: 2025-09-12
Description
There has been back-and-forth on the health risks of light or moderate alcohol consumption. Recent reviews have tried to narrow down the cancer risks associated with drinking.
Also, the heart benefits of GLP-1s like Ozempic and Wegovy could be dependent on your BMI, based on a new study in people with type 2 diabetes.
And an update from the Australian Health Practitioner Regulation Agency (AHPRA) on GLP-1 prescribing practices.
References
- Alcohol and Cancer Risk - JAMA Insights
- Review of Evidence on Alcohol and Health - National Academies of Sciences, Engineering, and Medicine
- GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes
- Incidence of GLP‐1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011–2022: a retrospective open cohort study
- Joint statement on professional responsibilities for prescribing and dispensing medicines - AHPRA
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
